Mellowhope Pharmaceutical

Guangdong Mellowhope Pharmaceutical is a Chinese biopharmaceutical company specialized in the research, development, and manufacturing of human vaccines and biological products. Established in 1994 and headquartered in Shantou, the company has established itself as a significant player in the infectious disease market, particularly through its high-quality human rabies vaccines produced using large-scale Vero cell culture technology. Mellowhope's commercial portfolio is anchored by its rabies vaccines and tetanus antitoxin, while its R&D pipeline focuses on seasonal influenza and other critical prophylactic vaccines. The company operates modern, GMP-compliant manufacturing facilities and has historically expanded its reach through both domestic sales and international pharmaceutical distribution.